MFDS to Host '2023 Convergence Medical Products Conference' on July 2

The Ministry of Food and Drug Safety (MFDS) will hold the ‘2023 Convergence Medical Products Conference’ on the 2nd of next month at EL Tower in Seoul, with the theme ‘Latest Domestic and International Regulatory Trends and Prospects for Convergence Medical Products.’

This conference is organized to bring together industry professionals related to convergence medical products, domestic and international experts, and the MFDS to share the latest global regulatory trends and prospects, product development and review cases, and to discuss the development direction of the convergence medical products industry.

Convergence medical products refer to products that combine pharmaceuticals, medical devices, and quasi-drugs, such as drug-eluting stents (medical devices that release drugs).

The conference will be divided into two main topics: ‘Classification Cases and Regulatory Trends of Convergence Medical Products’ and ‘Review and Development Cases of Convergence Medical Products,’ featuring detailed lectures and Q&A sessions by MFDS and industry experts.

To enhance on-site communication and improve the effectiveness of rapid product development support, MFDS officials will provide direct consultations on classification of convergence medical products to companies that have pre-registered inquiries.

Those wishing to attend must apply online by the 26th of this month, and participation is free of charge.

The MFDS stated, “We expect that holding this convergence medical products conference will be an opportunity to help domestic companies strengthen their capabilities to rapidly commercialize safe and effective convergence medical products.”

This content was produced with the assistance of AI translation services.